Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T19:10:21.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of smoking status and MADRS retardation factor on response to low frequency repetitive transcranial magnetic stimulation for depression

Published online by Cambridge University Press:  23 March 2020

E. Poulet ,
F. Galvao ,
E. Haffen ,
D. Szekely ,
C. Brault ,
F. Haesebaert  and
J. Brunelin
E. Poulet*
Affiliation:
Inserm, U1028, CNRS, UMR5292, Lyon neuroscience research center, ΨR2 Team, université de LyonLyon69000, France University Lyon 1Villeurbanne69000, France Centre hospitalier Le VinatierBron69678, France Service de psychiatrie des urgences, hôpital Édouard-Herriot, CHU de LyonLyon69000, France
F. Galvao
Affiliation:
Inserm, U1028, CNRS, UMR5292, Lyon neuroscience research center, ΨR2 Team, université de LyonLyon69000, France University Lyon 1Villeurbanne69000, France Centre hospitalier Le VinatierBron69678, France
E. Haffen
Affiliation:
Department of clinical psychiatry, CIC-1431 Inserm, university hospital of Besançon, Besançon, France EA-481, université Bourgogne Franche-Comté, université Franche-Comté, Besançon, France FondaMental foundation, Créteil, France
D. Szekely
Affiliation:
Princess Grace hospital, department of psychiatry, Monaco, France
C. Brault
Affiliation:
Pôle « information médicale évaluation recherche » (IMER), CHU de Lyon 62, avenue Lacassagne, bâtiment A Lyon cedex 0369424, France
F. Haesebaert
Affiliation:
Inserm, U1028, CNRS, UMR5292, Lyon neuroscience research center, ΨR2 Team, université de LyonLyon69000, France University Lyon 1Villeurbanne69000, France Centre hospitalier Le VinatierBron69678, France
J. Brunelin
Affiliation:
Inserm, U1028, CNRS, UMR5292, Lyon neuroscience research center, ΨR2 Team, université de LyonLyon69000, France University Lyon 1Villeurbanne69000, France Centre hospitalier Le VinatierBron69678, France
*
*Corresponding author. Service de psychiatrie des urgences, hôpital E’douard-Herriot, Pavillon N, 5, place d’Arsonval, 69437 Lyon cedex 03, France.E-mail address:[email protected](E. Poulet).
Get access

Abstract

Background

Despite growing evidence supporting the clinical interest of repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression (TRD), little is known regarding the effects of clinical and sociodemographic factors on the clinical outcome in patients.

Methods

We retrospectively investigated the effects of clinical (using the 3-factor model of the Montgomery-Åsberg depression rating scale [MADRS] encompassing dysphoria, retardation and vegetative symptoms) and sociodemographic characteristics of participants on clinical outcome in a sample of 54 TRD patients receiving low frequency rTMS (1 Hz, 360 pulses) applied over the right dorsolateral prefrontal cortex combined with sham venlafaxine.

Results

Responders (n = 29) displayed lower retardation baseline scores (13.6 ± 2.9) than non-responders (15.6 ± 2.9; n = 25; P = 0.02). We also observed a significant difference between the numbers of ex-smokers in responders and non-responders groups; all ex-smokers (n = 8) were responders to rTMS (P = 0.005).

Conclusion

Low MADRS retardation factor and ex-smoker status is highly prevalent in responders to low frequency rTMS. Further studies are needed to investigate the predictive value of these factors.

Keywords

rTMSRetardationDepressionMADRSNicotineSmoking
Type
Original article
Information
European Psychiatry , Volume 38 , October 2016 , pp. 40 - 44
Copyright
Copyright © Elsevier Masson SAS 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization The global burden of disease: 2004 update 2004 http://www.who.int/entity/healthinfo/global_burden_disease/GBD_report_2004update_full.pdfGoogle Scholar
Fava, MDiagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;153(8): 649–659CrossRefGoogle Scholar
Kennedy, SHMilev, RGiacobbe, Pet al.Canadian network for mood and anxiety treatments (CANMAT). Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009;117(1):S44–S53CrossRefGoogle ScholarPubMed
Lefaucheur, JPAndré-Obadia, NAntal, Aet al.Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11): 2150–2206CrossRefGoogle Scholar
O’Reardon, JPSolvason, HBJanicak, PGet al.Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11): 1208–1216CrossRefGoogle ScholarPubMed
Berlim, MTVan den Eynde, FDaskalakis, ZJClinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology. 2013;38:543–551CrossRefGoogle ScholarPubMed
Eche, JMondino, MHaesebaert, FSaoud, MPoulet, EBrunelin, JLow- vs high-frequency repetitive transcranial magnetic stimulation as an add-on treatment for refractory depression. Front Psychiatry. 3 2012 13CrossRefGoogle ScholarPubMed
Chen, JZhou, CWu, Bet al.Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 2013;210:1260–1264CrossRefGoogle ScholarPubMed
Dumas, RPadovani, RRichieri, Ret al.Repetitive transcranial magnetic stimulation in major depression: response factor. Encephale. 2012;38(4): 360–368CrossRefGoogle ScholarPubMed
Silverstein, WKNoda, YBarr, MSet al.Neurobiological predictors of response to dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation in depression: a systematic review. Depress Anxiety. 2015;2(12): 871–891CrossRefGoogle Scholar
Fregni, FMarcolin, MAMyczkowski, Met al.Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9(6): 641–654CrossRefGoogle ScholarPubMed
Lisanby, SHHusain, MMRosenquist, PBet al.Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2): 522–534CrossRefGoogle Scholar
Montgomery, SAÅsberg, MA new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389CrossRefGoogle ScholarPubMed
Benazzi, FFactor analysis of the Montgomery Asberg depression rating scale in 251 bipolar II and 306 unipolar depressed outpatients. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(7): 1369–1376CrossRefGoogle ScholarPubMed
Parker, RDFlint, EPBosworth, HBPieper, CFSteffens, DCA three-factor analytic model of the MADRS in geriatric depression. Int J Geriatr Psychiatry. 2003;18(1): 73–77CrossRefGoogle ScholarPubMed
Suzuki, AAoshima, TFukasawa, Tet al.A three-factor model of the MADRS in major depressive disorder. Depress Anxiety. 2005;21:95–97CrossRefGoogle ScholarPubMed
Quilty, LCRobinson, JJRolland, JPFruyt, FDRouillon, FBagby, RMThe structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression. Int J Methods Psychiatr Res. 2013;22(3): 175–184Google ScholarPubMed
Okazaki, MTominaga, KHiguchi, Het al.Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg depression rating scale for treatment-resistant depressed patients. J ECT. 2010;26(2): 87–90CrossRefGoogle ScholarPubMed
Alonzo, AChan, GMartin, Det al.Transcranial direct current stimulation (tDCS) for depression: analysis of response using a three-factor structure of the Montgomery-Åsberg depression rating scale. J Affect Disord. 2013;150(1): 91–95CrossRefGoogle ScholarPubMed
Higuchi, HSato, KYoshida, Ket al.Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg depression rating scale for major depressive disorders in Japanese patients. Psychiatry Clin Neurosci. 2008;62(3): 301–306CrossRefGoogle ScholarPubMed
Brunelin, JJalenques, ITrojak, Bet al.The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT. Brain Stimul. 2014;7(6): 855–863CrossRefGoogle ScholarPubMed
Brakemeier, ELLuborzewski, ADanker-Hopfe, Het al.Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 2007;41(5): 395–403CrossRefGoogle Scholar
Brakemeier, ELWilbertz, GRodax, Set al.Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. J Affect Disord. 2008;108(1–2):59–70CrossRefGoogle ScholarPubMed
Buchan, HJohnstone, EMcPherson, KPalmer, RLCrow, TJBrandon, SWho benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry. 1992;160:355–359CrossRefGoogle ScholarPubMed
O’Leary, DGill, DGregory, SShawcross, CWhich depressed patients respond to ECT? The Nottingham results. J Affect Disord. 1995;33:245–250CrossRefGoogle ScholarPubMed
Hickie, IMason, CParker, GBrodaty, HPrediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry. 1996;169:68–74CrossRefGoogle ScholarPubMed
Fitzgerald, PBBrown, TLMarston, Net al.Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003;60(10): 1002–1008Google ScholarPubMed
Holtzheimer, PERusso, JClaypoole, KEet al.Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety. 2004;19(1): 24–30CrossRefGoogle ScholarPubMed
Pascual-Leone, ARubio, BPallardo, FCatala, MDRapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996;348:233–237CrossRefGoogle ScholarPubMed
Grunhaus, LSchreiber, SDolberg, OTPolak, DDannon, PNA randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry. 2003;53:324–331CrossRefGoogle ScholarPubMed
Schüle, CZwanzger, PBaghai, Tet al.Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study. J Psychiatr Res. 2003;37:145–153CrossRefGoogle Scholar
Aguirre, ICarretero, BIbarra, Oet al.Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression. J Affect Disord. 2011;130(3): 466–469CrossRefGoogle ScholarPubMed
Krönke, KMWolff, MBenz, Aet al.Successful smoking cessation is associated with prefrontal cortical function during a Stroop task: a preliminary study. Psychiatry Res. 2015;234(1): 52–56CrossRefGoogle ScholarPubMed
Nestor, LMcCabe, EJones, Jet al.Differences in “bottom-up” and “top-down” neural activity in current and former cigarette smokers: evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. Neuroimage. 2011;56(4): 2258–2275CrossRefGoogle ScholarPubMed
Brunelin, JHasan, AHaesebaert, FNitscheMA, Poulet, ENicotine smoking prevents the effects of frontotemporal transcranial direct current stimulation (tDCS) in hallucinating patients with schizophrenia. Brain Stimul. 2015;8(6): 1225–1227CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.